IntelliProve is a Belgium-based HealthTech startup that specializes in preventive healthcare. The company has developed a technology that can accurately assess health parameters within seconds through optical measurement of the face. By leveraging novel signal processing and computer vision technology, IntelliProve enables digital health platforms and apps to enhance user engagement and overall well-being through hyper-personalized health monitoring and guidance. The innovative solution offers fast, contactless, and seamlessly integrated measurement of physiological and mental health parameters, making it a valuable addition to any healthcare or well-being application. In November 2022, IntelliProve secured a €1.00M Seed Round investment from imec.istart and Wit-Gele Kruis van Vlaanderen, demonstrating the confidence of investors in the company's vision and potential. With its cutting-edge biomarker technology, IntelliProve is poised to deliver quantitative and real-time health insights, positioning itself as a transformative player in the Health Care industry. More information about IntelliProve can be found on their website here.